Metabolic syndrome and obesity as additional factors that determine clinical response in chronic hepatitis C.
Tugrul
T
Purnak
Cumali
C
Efe
Yavuz
Y
Beyazit
Ersan
E
Ozaslan
D019698:Hepatitis C, Chronic / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D024821:Metabolic Syndrome / Q000150:complications; D009765:Obesity / Q000150:complications; D014807:Vitamin D / Q000097:blood
D014807:Vitamin D; D007372:Interferons